PDSB logo

PDS Biotechnology (PDSB) Selling, General & Administrative Expenses

Annual SGA

$15.28 M
+$3.04 M+24.84%

December 31, 2023

Summary

Performance

1-Year Change

+24.84%

3-Year Change

+119.01%

5-Year Change

+6.94%

15-Year Change

-13.44%

PDSB SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

34.76%
PDSB annual SGA is higher than 34.76% of companies in Healthcare sector

High & Low

All-time High

$17.66 M
PDSB annual SGA is currently -13.44% below its historical high of $17.66 million

3-Year Low

$10.18 M
PDSB annual SGA is currently +50.05% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
PDSB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 27, 2025
PDSB next annual earnings announcement is scheduled for Mar 27, 2025

OtherPDSBexpensesmetrics:

Annual Total Expenses

$43.05 M
PDSB annual total expenses is $43.05 million

Annual Operating Expenses

$43.05 M
PDSB annual total operating expenses is $43.05 million

Annual Cost Of Goods Sold

-
PDSB annual cost of goods sold value is unknown

Annual Interest Expense

$4.21 M
PDSB annual interest expense is $4.21 million

Quarterly SGA

$3.37 M
-$781.80 K-18.81%

September 30, 2024

Summary

Performance

3-Month Change

-18.81%

1-Year Change

+14.74%

3-Year Change

-28.06%

5-Year Change

-28.06%

PDSB Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.38%
PDSB quarterly SGA is higher than 29.38% of companies in Healthcare sector

High & Low

All-time High

$12.84 M
PDSB quarterly SGA is currently -73.72% below its historical high of $12.84 million

3-Year Low

$2.67 M
PDSB quarterly SGA is currently +26.57% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PDSB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
PDSB next earnings announcement is scheduled for Mar 27, 2025

OtherPDSBexpensesmetrics:

Quarterly Total Expenses

$10.18 M
PDSB quarterly total expenses is $10.18 million

Quarterly Operating Expenses

$10.18 M
PDSB quarterly total operating expenses is $10.18 million

Quarterly Cost Of Goods Sold

-
PDSB quarterly cost of goods sold value is unknown

Quarterly Interest Expense

$1.21 M
PDSB quarterly interest expense is $1.21 million

TTM SGA

-$637.20 M
-$40.56 M-6.80%

September 30, 2024

Summary

Performance

3-Month Change

-4475.59%

1-Year Change

-4269.47%

3-Year Change

-4696.54%

5-Year Change

-4696.54%

PDSB TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

56.46%
PDSB TTM SGA is higher than 56.46% of companies in Healthcare sector

High & Low

All-time High

-$29.82 M

3-Year Low

-$637.20 M
PDSB TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PDSB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
PDSB next earnings announcement is scheduled for Mar 27, 2025

OtherPDSBexpensesmetrics:

Annual Total Expenses

$43.05 M
PDSB annual total expenses is $43.05 million

Annual Operating Expenses

$43.05 M
PDSB annual total operating expenses is $43.05 million

TTM Cost Of Goods Sold

-
PDSB TTM cost of goods sold value is unknown

TTM Interest Expense

$4.75 M
PDSB TTM interest expense is $4.75 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$15.28 M
PDSB annual SGA is $15.28 million

Annual Operating Expenses

$43.05 M
PDSB annual total operating expenses is $43.05 million

Annual Cost Of Goods Sold

-
PDSB annual cost of goods sold value is unknown

PDSB Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+24.8%+14.7%-4269.5%
3 y3 years+119.0%-28.1%-4696.5%
5 y5 years+6.9%-28.1%-4696.5%

PDSB Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+50.0%-28.1%+26.6%-204.4%at low
5 y5-yearat high+119.0%-28.1%+121.8%-649.2%at low
alltimeall time-13.4%+662.6%-73.7%+747.1%-2036.9%+14.0%

PDS Biotechnology Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$3.37 M(-18.8%)
$13.87 M(-4.8%)
Jun 2024
-
$4.16 M(+22.5%)
$14.56 M(-3.5%)
Mar 2024
-
$3.39 M(+15.4%)
$15.10 M(-1.2%)
Dec 2023
$15.28 M(+24.8%)
$2.94 M(-27.8%)
$15.28 M(+1.8%)
Sep 2023
-
$4.07 M(-13.2%)
$15.01 M(+8.3%)
Jun 2023
-
$4.69 M(+31.1%)
$13.86 M(+10.9%)
Mar 2023
-
$3.58 M(+34.2%)
$12.50 M(+2.1%)
Dec 2022
$12.24 M(+20.2%)
$2.67 M(-8.9%)
$12.24 M(-2.1%)
Sep 2022
-
$2.93 M(-12.2%)
$12.51 M(-2.7%)
Jun 2022
-
$3.33 M(+0.4%)
$12.86 M(+8.3%)
Mar 2022
-
$3.32 M(+13.1%)
$11.87 M(+16.5%)
Dec 2021
$10.18 M(+46.0%)
$2.93 M(-10.4%)
$10.18 M(+15.7%)
Sep 2021
-
$3.27 M(+39.8%)
$8.80 M(+19.4%)
Jun 2021
-
$2.34 M(+43.1%)
$7.37 M(+12.5%)
Mar 2021
-
$1.64 M(+5.6%)
$6.55 M(-6.1%)
Dec 2020
$6.98 M(-36.5%)
$1.55 M(-16.1%)
$6.98 M(-1.0%)
Sep 2020
-
$1.85 M(+21.3%)
$7.05 M(-14.8%)
Jun 2020
-
$1.52 M(-26.1%)
$8.27 M(-9.4%)
Mar 2020
-
$2.06 M(+26.9%)
$9.14 M(-16.8%)
Dec 2019
$10.98 M
$1.62 M(-47.1%)
$10.98 M(-50.5%)
Sep 2019
-
$3.07 M(+28.7%)
$22.20 M(+13.0%)
DateAnnualQuarterlyTTM
Jun 2019
-
$2.38 M(-39.0%)
$19.65 M(+11.2%)
Mar 2019
-
$3.91 M(-69.6%)
$17.66 M(+23.6%)
Dec 2018
$14.29 M(-19.1%)
$12.84 M(+2387.5%)
$14.29 M(+112.0%)
Sep 2018
-
$516.20 K(+29.6%)
$6.74 M(-34.0%)
Jun 2018
-
$398.40 K(-25.6%)
$10.21 M(-27.0%)
Mar 2018
-
$535.80 K(-89.9%)
$13.99 M(-20.8%)
Dec 2017
$17.66 M(+20.2%)
$5.29 M(+32.6%)
$17.66 M(+6.8%)
Sep 2017
-
$3.99 M(-4.4%)
$16.53 M(+2.7%)
Jun 2017
-
$4.17 M(-0.7%)
$16.09 M(+5.8%)
Mar 2017
-
$4.20 M(+1.0%)
$15.20 M(+3.5%)
Dec 2016
$14.69 M(+69.6%)
$4.16 M(+17.1%)
$14.69 M(+3.9%)
Sep 2016
-
$3.55 M(+8.0%)
$14.13 M(+12.5%)
Jun 2016
-
$3.29 M(-10.8%)
$12.56 M(+13.8%)
Mar 2016
-
$3.69 M(+2.2%)
$11.03 M(+27.4%)
Dec 2015
$8.66 M(+83.4%)
$3.61 M(+82.4%)
$8.66 M(+38.9%)
Sep 2015
-
$1.98 M(+12.0%)
$6.23 M(+15.5%)
Jun 2015
-
$1.77 M(+34.6%)
$5.40 M(+48.6%)
Mar 2015
-
$1.31 M(+11.1%)
$3.63 M(+56.5%)
Dec 2014
$4.72 M(+135.6%)
$1.18 M(+3.4%)
$2.32 M(+103.4%)
Sep 2014
-
$1.14 M
$1.14 M
Dec 2013
$2.00 M
-
-

FAQ

  • What is PDS Biotechnology annual SGA?
  • What is the all time high annual SGA for PDS Biotechnology?
  • What is PDS Biotechnology annual SGA year-on-year change?
  • What is PDS Biotechnology quarterly SGA?
  • What is the all time high quarterly SGA for PDS Biotechnology?
  • What is PDS Biotechnology quarterly SGA year-on-year change?
  • What is PDS Biotechnology TTM SGA?
  • What is the all time high TTM SGA for PDS Biotechnology?
  • What is PDS Biotechnology TTM SGA year-on-year change?

What is PDS Biotechnology annual SGA?

The current annual SGA of PDSB is $15.28 M

What is the all time high annual SGA for PDS Biotechnology?

PDS Biotechnology all-time high annual SGA is $17.66 M

What is PDS Biotechnology annual SGA year-on-year change?

Over the past year, PDSB annual SGA has changed by +$3.04 M (+24.84%)

What is PDS Biotechnology quarterly SGA?

The current quarterly SGA of PDSB is $3.37 M

What is the all time high quarterly SGA for PDS Biotechnology?

PDS Biotechnology all-time high quarterly SGA is $12.84 M

What is PDS Biotechnology quarterly SGA year-on-year change?

Over the past year, PDSB quarterly SGA has changed by +$433.60 K (+14.74%)

What is PDS Biotechnology TTM SGA?

The current TTM SGA of PDSB is -$637.20 M

What is the all time high TTM SGA for PDS Biotechnology?

PDS Biotechnology all-time high TTM SGA is -$29.82 M

What is PDS Biotechnology TTM SGA year-on-year change?

Over the past year, PDSB TTM SGA has changed by -$652.48 M (-4269.47%)